A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for Coronavirus Spike Protein Activation
Overview
Affiliations
Enveloped viruses such as coronaviruses or influenza virus require proteolytic cleavage of their fusion protein to be able to infect the host cell. Often viruses exhibit cell and tissue tropism and are adapted to specific cell or tissue proteases. Moreover, these viruses can introduce mutations or insertions into their genome during replication that may affect the cleavage, and thus can contribute to adaptations to a new host. Here, we present a fluorogenic peptide cleavage assay that allows a rapid screening of peptides mimicking the cleavage site of viral fusion proteins. The technique is very flexible and can be used to investigate the proteolytic activity of a single protease on many different substrates, and in addition, it also allows exploration of the activity of multiple proteases on one or more peptide substrates. In this study, we used peptides mimicking the cleavage site motifs of the coronavirus spike protein. We tested human and camel derived Middle East Respiratory Syndrome coronaviruses (MERS-CoV) to demonstrate that single and double substitutions in the cleavage site can alter the activity of furin and dramatically change cleavage efficiency. We also used this method in combination with bioinformatics to test furin cleavage activity of feline coronavirus spike proteins from different serotypes and strains. This peptide-based method is less labor- and time intensive than conventional methods used for the analysis of proteolytic activity for viruses, and results can be obtained within a single day.
Schwerdtner M, Schmacke L, Nave J, Limburg H, Steinmetzer T, Stein D Viruses. 2024; 16(11).
PMID: 39599912 PMC: 11599139. DOI: 10.3390/v16111798.
Virion morphology and on-virus spike protein structures of diverse SARS-CoV-2 variants.
Ke Z, Peacock T, Brown J, Sheppard C, Croll T, Kotecha A EMBO J. 2024; 43(24):6469-6495.
PMID: 39543395 PMC: 11649927. DOI: 10.1038/s44318-024-00303-1.
Mjokane N, Akintemi E, Sabiu S, Gcilitshana O, Albertyn J, Pohl C Virol J. 2024; 21(1):58.
PMID: 38448991 PMC: 10919004. DOI: 10.1186/s12985-024-02331-z.
Lubinski B, Jaimes J, Whittaker G bioRxiv. 2022; .
PMID: 35923311 PMC: 9347273. DOI: 10.1101/2022.04.20.488969.
Lubinski B, Frazier L, Phan M, Bugembe D, Cunningham J, Tang T Microbiol Spectr. 2022; 10(4):e0151422.
PMID: 35766497 PMC: 9430374. DOI: 10.1128/spectrum.01514-22.